- Home
- PBYI vs ESGL Comparison
PBYI vs ESGL Comparison
Compare PBYI & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- ESGL
- Stock Information
- Founded
- PBYI 2010
- ESGL 1999
- Country
- PBYI United States
- ESGL Singapore
- Employees
- PBYI N/A
- ESGL N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- ESGL
- Sector
- PBYI Health Care
- ESGL
- Exchange
- PBYI Nasdaq
- ESGL Nasdaq
- Market Cap
- PBYI 171.7M
- ESGL 154.3M
- IPO Year
- PBYI N/A
- ESGL N/A
- Fundamental
- Price
- PBYI $4.64
- ESGL $3.56
- Analyst Decision
- PBYI Strong Buy
- ESGL
- Analyst Count
- PBYI 1
- ESGL 0
- Target Price
- PBYI $7.00
- ESGL N/A
- AVG Volume (30 Days)
- PBYI 648.1K
- ESGL 22.6K
- Earning Date
- PBYI 11-06-2025
- ESGL 09-23-2025
- Dividend Yield
- PBYI N/A
- ESGL N/A
- EPS Growth
- PBYI 434.29
- ESGL N/A
- EPS
- PBYI 0.97
- ESGL N/A
- Revenue
- PBYI $238,062,000.00
- ESGL $6,099,784.00
- Revenue This Year
- PBYI N/A
- ESGL N/A
- Revenue Next Year
- PBYI N/A
- ESGL N/A
- P/E Ratio
- PBYI $4.76
- ESGL N/A
- Revenue Growth
- PBYI 8.63
- ESGL N/A
- 52 Week Low
- PBYI $2.32
- ESGL $0.90
- 52 Week High
- PBYI $6.07
- ESGL $3.87
- Technical
- Relative Strength Index (RSI)
- PBYI 49.99
- ESGL 65.57
- Support Level
- PBYI $4.49
- ESGL $3.40
- Resistance Level
- PBYI $5.22
- ESGL $3.73
- Average True Range (ATR)
- PBYI 0.26
- ESGL 0.25
- MACD
- PBYI -0.12
- ESGL 0.07
- Stochastic Oscillator
- PBYI 22.33
- ESGL 81.55
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.